Evidence map›Paper›PMID 35385900›Full record

ArticleNeurointervention2022

The Use of a Pipeline Embolization Device for Treatment of a Ruptured Dissecting Middle Cerebral Artery M3/M4 Aneurysm: Challenges and Technical Considerations.

Robert P Berwanger, Madeline C Hoover, John A Scott, Andrew J DeNardo, Krishna Amuluru, Troy D Payner, Charles G Kulwin, Daniel H Sahlein

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurointervention, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Robert P BerwangerDepartment of Neurosurgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Madeline C HooverDepartment of Neurosurgery, Indiana University School of Medicine, Indianapolis, IN, USA.
John A ScottDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
Andrew J DeNardoDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
Krishna AmuluruDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
Troy D PaynerDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
Charles G KulwinDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
Daniel H SahleinDivision of Interventional Neuroradiology, Goodman Campbell Brain and Spine at Ascension St. Vincent Hospital, Carmel, IN, USA.
St. Vincent Hospital · USIndiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prompt, effective treatment is necessary following aneurysmal subarachnoid hemorrhage to prevent recurrent rupture, which is thought to double mortality. Atypical ruptured aneurysms, such as blister or dissecting pseudoaneurysms, or those that are unusually distal in the middle cerebral artery (MCA) are challenging to treat with either open or endovascular options, though the pipeline embolization device (PED) has shown promise in multiple case series. We present a case of a ruptured dissecting pseudoaneurysm in the distal MCA (distal M3/proximal M4) prefrontal division in an healthy young patient (<60 years) successfully treated with a PED. The PED was chosen both as the only vessel sparing option in the young patient as well as for its potential as a vessel sacrifice tool if the pseudoaneurysm was felt to be incompletely treated, which in this case was not necessary-though would have leveraged the thrombogenicity of the device as a therapeutic advantage.

Indexed as

Embolization, therapeuticMiddle cerebral arteryPseudoaneurysmSubarachnoid hemorrhage

Identifiers

PMID35385900
PMCPMC9256466
OpenAlexW4225810565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.